Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) PT Raised to $176 at Barclays

July 17, 2025 4:29 AM
Barclays analyst Matt Miksic raised the price target on Johnson & Johnson (NYSE: JNJ) to $176.00 (from $165.00) while maintaining a Equalweight rating.

Categories

Analyst PT Change

Next Articles